Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    "Pseudomyxoma peritonei"
Show Display Options
RSS Create an RSS feed from your search for:
"Pseudomyxoma peritonei"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Results of CRS and Debulking in PMP Patients
Condition: Pseudomyxoma Peritonei
Intervention:
2 Active, not recruiting Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Conditions: Leydig Cell Tumor;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Pseudomyxoma Peritonei;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Cavity Cancer;   Recurrent Uterine Sarcoma;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer
Interventions: Radiation: stereotactic body radiation therapy;   Drug: carboplatin;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
3 Enrolling by invitation Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C
Conditions: Peritoneal Carcinomatosis;   Colorectal Cancer;   Appendiceal Cancer;   Peritoneal Mesothelioma;   Pseudomyxoma Peritonei;   Gastric Cancer
Intervention: Procedure: HIPEC
4 Completed Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Conditions: Advanced Malignant Mesothelioma;   Carcinoma of the Appendix;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Pseudomyxoma Peritonei;   Recurrent Colon Cancer;   Recurrent Malignant Mesothelioma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Stage III Colon Cancer;   Stage III Ovarian Epithelial Cancer;   Stage III Ovarian Germ Cell Tumor;   Stage IV Colon Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Behavioral: HIPEC Orientation;   Behavioral: Consultation with Survivorship Navigator;   Other: Questionnaires
5 Recruiting Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Conditions: Peritoneal Carcinomatosis;   Pseudomyxoma Peritonei;   Peritoneal Mesothelioma
Intervention:
6 Active, not recruiting Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Conditions: Anxiety Disorder;   Depression;   Fatigue;   Leydig Cell Tumor;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Pain;   Peritoneal Carcinomatosis;   Pseudomyxoma Peritonei;   Recurrent Breast Cancer;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Gestational Trophoblastic Tumor;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Cavity Cancer;   Recurrent Uterine Sarcoma;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: psychosocial assessment and care;   Behavioral: behavioral intervention;   Other: cognitive intervention;   Other: educational intervention
7 Recruiting Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Conditions: Pseudomyxoma Peritonei.;   Colorectal Carcinoma.;   Ovarian Carcinoma.;   Mesothelioma.
Intervention: Other: Observational study.
8 Terminated A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis
Condition: Peritoneal Neoplasms
Interventions: Procedure: Surgical debulking with peritonectomy;   Drug: Intraperitoneal 5FU;   Drug: FOLFOX
9 Completed Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
Condition: Cancer
Interventions: Drug: floxuridine;   Drug: leucovorin calcium;   Drug: oxaliplatin

Indicates status has not been verified in more than two years